Rankings / Immune & Inflammation
2'-fucosyllactose (2'-FL human milk oligosaccharide)
Immune & Inflammation · Human milk oligosaccharide / prebiotic
Tier B
Bottom line
Read Off Label grades 2'-fucosyllactose (2'-FL human milk oligosaccharide) as B (6.8/10) based on moderate evidence, low-med benefit magnitude, and a low-risk safety profile.
This entry covers the specific human-milk oligosaccharide 2'-FL rather than the broader inulin or FOS category.
Studied, labeled, or reported-use context: Adult studies have used 3-20 g/day depending on protocol; tolerability protocols commonly begin at 1-3… — OTC / dietary ingredient; not individualized guidance.
What the evidence says
This entry covers the specific human-milk oligosaccharide 2'-FL rather than the broader inulin or FOS category. The 2025 Stanford/Abbott older-adult RCT missed its primary cytokine-response endpoint but increased Bifidobacterium and shifted serum insulin, HDL, FGF21, metabolites, and proteomic signals; Bifidobacterium responders showed additional metabolic/proteomic changes and better visual-memory performance. The findings are preliminary for healthy-aging outcomes, with responder biology and industry funding affecting interpretation.
Mechanism
Selective human-milk-oligosaccharide prebiotic that feeds HMO-utilizing Bifidobacterium species, modulates mucosal immune signaling, gut metabolites, gut barrier biology, and systemic metabolic/immune markers.
Studied, labeled, or reported dose & route
Adult studies have used 3-20 g/day depending on protocol; tolerability protocols commonly begin at 1-3 g/day and increase toward the product or study dose.
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about 2'-fucosyllactose (2'-FL human milk oligosaccharide)'s effects?
- Read Off Label rates the evidence for 2'-fucosyllactose (2'-FL human milk oligosaccharide) as Moderate and the benefit magnitude as low-med, producing an overall grade of B (6.8/10). This entry covers the specific human-milk oligosaccharide 2'-FL rather than the broader inulin or FOS category.
- What safety findings are reported for 2'-fucosyllactose (2'-FL human milk oligosaccharide)?
- 2'-fucosyllactose (2'-FL human milk oligosaccharide) has a low risk profile in the database. Low (GI bloating possible; long-term adult outcome data limited; response may depend on baseline Bifidobacterium) Legal status: OTC / dietary ingredient.
- What doses or routes are reported for 2'-fucosyllactose (2'-FL human milk oligosaccharide)?
- Adult studies have used 3-20 g/day depending on protocol; tolerability protocols commonly begin at 1-3 g/day and increase toward the product or study dose. This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does 2'-fucosyllactose (2'-FL human milk oligosaccharide) work?
- Selective human-milk-oligosaccharide prebiotic that feeds HMO-utilizing Bifidobacterium species, modulates mucosal immune signaling, gut metabolites, gut barrier biology, and systemic metabolic/immune markers.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.